Call to arrange a consultation
+1 416 777 0888
Search the site
Genentech Inc. v Pfizer Canada Inc.
2018
T-317-18
Resolved
New PM(NOC) Regulations
Motion/Application under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)
Counsel to:
Pfizer Canada Inc.
The decision is reported
here.
Meet the team
